Immupharma Share Discussion Threads

[che7win] 14/5/2018 12:05

Growth, Exactly my point. Ignore all the negative unsubstantiated nonsense here and listen to the company.My point is made?

[che7win] 14/5/2018 12:03

Spmc, No thanks, why take a chance there when we have the real upside here.

[growthinvestor2001] 14/5/2018 12:02

Che7win - If you not a paid PR mouthpiece for IMM you should be!

Face it, you are pretty much on your own pumping this one now. I'd just stop embarrising yourself and wait for an RNS like the rest of us because you constantly saying how confident you are and happy you are is laughable based on where the price is and amidst a total news blackout.

Seriously - just give it a rest - like I said before - don't you think you did enough damage last time?

[spmc] 14/5/2018 12:01

Guys trial results for Evgen Pharma are expected on Wednesday. They have three presentations lined up the first one on the 16 May 2018 and the trial results are expected to be announced the morning before the first presentation. Broker Northland expects SFX-01 to meet the safety and efficacy endpoints for both trials and have a price target of 113p that's 6.5 times the current share price. So results due Wednesday and expected to be positive and it should at least triple from these low levels on good results, it's a screaming buy. Only today and tomorrow left to get in. Going to move some more of my holdings from here and move them back on Thursday.

[nobbygnome] 14/5/2018 11:56

And your evidence is? Been talking to lying Tim by any chance?

Nobby

[nobbygnome] 14/5/2018 11:49

PS If they do a much larger trial, there is a slim chance but who on earth would take the risk of paying for that!

[nobbygnome] 14/5/2018 11:48

So are you saying Benlysta is going to be taken off the market? LOL you really haven't got a clue.

With a p value of almost 0.3 on the primary endpoint agreed with the regulator, Lupuzor has no chance of reaching the market. GSK's lawyers will make sure that is true!

Nobby

[che7win] 14/5/2018 11:44

Lupuzor will 100% get to market, Benlysta is a troubled drug with numbered days.First efficacious and safe drug for Lupus and first drug that provides complete remission for a subset of patients.This little piggy is going to market.

[nobbygnome] 14/5/2018 11:41

We have a drug which is proven not to work in multiple trials at this dose. Lupuzor has no chance of getting to market with the current data and the price is beginning to reflect that. They need to get on with sorting out the dosing problem and move on to a new indication!

Nobby

[che7win] 14/5/2018 11:38

Im looking forward to THIS dosage getting to market and the message getting out there.Very confident on that front.I'm sure the market will rerate here when we get further details.We have a drug that patients need and want (which is why we also have nervous competitors)

[nobbygnome] 14/5/2018 11:29

Lupuzor has no chance of getting to market with the current data and the price is beginning to reflect that. They need to get on with sorting out the dosing problem and move on to a new indication!

Nobby

[datait] 14/5/2018 11:20

Timbrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr

[datait] 14/5/2018 09:38

25p coming your way folks no volume only way is down

[che7win] 14/5/2018 09:38

Francis,
Excellent post, I agree with all your statements.

This drug is very much alive and will get to market, I have no doubts on that front.

Very much think we are undervalued at this price and I'm confident we will be much higher from here in future.

[cudmore] 14/5/2018 08:59

Big news at HEMO but not reported on ADVFN. IMM will be next. Buy on any dips and wait for the news to drop.

[coldspring] 14/5/2018 08:54

Based on what? Unless you are trading for 10% then the only thing that will really move this is news via an RNS.

[au24] 14/5/2018 08:37

Not looking good

[chesty1] 14/5/2018 08:36

Pumpers have moved on again

[ny boy] 14/5/2018 08:31

Daily vols drying up, support lost at 35.5p

I think many have moved onto (HEMO) dyor as usual

Range here still 20-50p approx, news flow, or lack of it,will see a movement either way within this range imho

[nigsrodders] 13/5/2018 23:02

Francisgalton. Great post. We just need patience before positive news from FDA and partner discussions. Keep the faith.

[hamila01] 13/5/2018 22:01

Great post francisgalton. I'm looking forward to seeing more detail from the analysis which I hope manages to shut the doomsayers up.Even better would be news of a deal with a large pharma.

[pretax2] 13/5/2018 21:42

I hold zero stock here but lost out on the top line results.

My impartial opinion of IMM (in short) is that it's not a dead duck, and a positive RNS will see the share price sharply rise (assuming it's positive - it may not be).
Either way IMM have an uphill battle.

I'm reminded of someone on ADVFN who once said the first piece of bad news is usually not the last, so listened to my guts and sold. Reinvested in MTFB which is like owning IMM (depressed SP) but with a positive P3 trial result.

The best material for making silk purses is silk (as Buffet would say)

[badger60] 13/5/2018 17:05

java scriptYou're making yourself look very stupid complaining about someone who gave you a tip which went up 21% the next day....... Perhaps it's because you're too used to being a loser.........